Home > Insider Trading > Filing (0001171843-16-011868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1582313	Xenon Pharmaceuticals Inc.	XENE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
938801	A Frank Holler	C/O Xenon Pharmaceuticals Inc 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Disposition	2016-08-16	6,863	$8.25	169,006	No	4	S	Direct
Common Shares	Disposition	2016-08-17	1,600	$7.89	167,406	No	4	S	Direct
Common Shares	Disposition	2016-08-18	9,599	$7.70	157,807	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	1,184	Indirect	By Spouse

Footnotes

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $7.89 to $7.90 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.